»Go to related Japanese page in JPubb

Loading

Press Releases by "Kyowa Hakko Kirin Co., Ltd."


You may also like to check companies from Kyowa Hakko Kirin Co., Ltd.'s related industry or location as follows: Chemicals, Tokyo

« Previous12Next »
1 - 50 of 59 for your search
Conversion of Kyowa Hakko Kirin Korea Co., Ltd. into wholly owned subsidiary
[ Chemicals | 2012-09-26]
Kyowa Hakko Kirin returns to Otsuka Pharmaceutical the rights to develop and market Busulfex®, for use as a part of conditioning regimen prior to hematopoietic progenitor cell transplantation, in Japan and in Asian Countries & Regions
[ Chemicals | 2012-09-14]
Pasetocin® and Sawacillin®: Joint Application Seeking Approval for Additional Indication for Helicobacter pylori Eradication by Triple Therapy with Proton Pump Inhibitors and either Clarithromycin or Metronidazole
[ Chemicals | 2012-08-31]
Kyowa Hakko Kirin Initiates Pivotal Phase 2 Trial of Mogamulizumab (KW-0761) in Patients with Adult T-cell Leukemia-Lymphoma in the United States and Europe
[ Chemicals | 2012-08-23]
Launch of Apokyn® Subcutaneous Injection 30 mg for Treatment of Parkinson's Disease
[ Chemicals | 2012-07-26]
Otsuka Pharmaceutical and Kyowa Hakko Kirin announce strategic alliance in the fields of diabetes and oncology
[ Chemicals | 2012-06-29]
Launch and Co-Promotion of "MINIRINMELT® OD Tablet 120μg / 240μg", A Treatment of Nocturnal Enuresis / Bedwetting
[ Chemicals | 2012-05-29]
Change in the Company Name of JEIL-KIRIN PHARMACEUTICAL INC.
[ Chemicals | 2012-05-25]
Kyowa Medex Launched POTELIGEO® TEST IHC and POTELIGEO® TEST FCM,Companion Diagnostics of POTELIGEO® Injection in Japan
[ Chemicals | 2012-05-07]
Change of the Name of Kirin Kunpeng (China) Bio-Pharmaceutical Co., Ltd.
[ Chemicals | 2012-04-26]
Announcement regarding the Filing in Japan ofan Application for Marketing Approval of KW-6002 forParkinson's Disease Treatment
[ Chemicals | 2012-04-02]
New Drug Application Approval for POTELIGEO® (Mogamulizumab) Injection in Japan, a Therapeutic Antibody for Adult T-cell Leukemia-Lymphoma (ATL)
[ Chemicals | 2012-03-30]
Kyowa Medex Receives Approval for POTELIGEO® TEST IHC and POTELIGEO® TEST FCM, Companion Diagnostics of POTELIGEO® Injection in Japan
[ Chemicals | 2012-03-30]
Announcement regarding Marketing Authorization Approval in Japan of Apokyn® Subcutaneous Injection 30 mg (Apomorphine Hydrochloride Hydrate) for Treatment of Parkinson's Disease
[ Chemicals | 2012-03-30]
Establishment of Fujifilm Kyowa Kirin Biologics -Joint-Venture of Fujifilm and Kyowa Hakko Kirin for the development, manufacturing and sales of biosimilars-
[ Chemicals | 2012-03-27]
English version of the "Kyowa Hakko Kirin Group CSR Report 2011" has been issued
[ Chemicals | 2011-12-07]
Launch of gastrointestinal prokinetic agents: NAUZELIN® OD Tablets 5 and NAUZELIN® OD Tablets 10
[ Chemicals | 2011-12-05]
Fujifilm and Kyowa Hakko Kirin to set up a joint venture for the development of biosimilars
[ Chemicals | 2011-11-16]
Launch of Allelock 0.5% Granules for the Treatment of Allergic Symptoms - New Dosage Form
[ Chemicals | 2011-11-15]
Kyowa Hakko Kirin Q3 (9 months) Operating Profit up 15.8%
[ Chemicals | 2011-10-27]
Kyowa Hakko Kirin Additional Indication Application for Synthesized Penicillin "PASETOCIN®"
[ Chemicals | 2011-08-10]
Kyowa Hakko Kirin Announces Commencement of Phase 3 International Clinical Study of ARQ 197 (Tivantinib) in Patients with Non-Small Cell Lung Cancer in Asia
[ Chemicals | 2011-08-09]
Kyowa Hakko Kirin Submitted New Drug Application in Japan for KW-6500 (Apomorphine Hydrochloride Hydrate)
[ Chemicals | 2011-07-26]
Kyowa Hakko Kirin announces a Commencement of Phase 3 Clinical Study for KW-3357 in Japan
[ Chemicals | 2011-06-29]
Kyowa Hakko Kirin Announces a Plan to Build a New Pharmaceutical Plant
[ Chemicals | 2011-06-29]
Approval of Additional Indication, Dosage and Administration of Depakene for suppressing the Onset of Migraine Attacks
[ Chemicals | 2011-06-16]
Termination of the North American licensing agreement for KW-6002 (Istradefylline)
[ Chemicals | 2011-06-03]
Ferring and Kyowa Hakko Kirin announceco-promotion of Desmopressin acetate hydrate orally disintegrating tablet
[ Chemicals | 2011-06-01]
Kyowa Hakko Bio announces the commencement ofcommercial production of cis-4-Hydroxy-L-proline
[ Chemicals | 2011-05-12]
New in vitro diagnostic reagents and analyzer for various allergens Launch announcement for Allerport® HRT and its dedicated analyzer, the Allerport HRT System
[ Chemicals | 2011-05-10]
Kyowa Hakko Kirin Announces Results of Phase lll Clinical Study of KW-6002 (Istradefylline) for Parkinson's Disease in Japan
[ Chemicals | 2011-05-10]
Kyowa Hakko Kirin submitted New Drug Application in Japan for KW-0761, a Therapeutic Antibody for Adult T-cell Leukemia-Lymphoma (ATL)
[ Chemicals | 2011-04-26]
Kyowa Medex Submitted New Drug Application for In Vitro Diagnostic Reagent to Detect CCR4 Proteins in Japan
[ Chemicals | 2011-04-26]
Kyowa Medex forms a joint business with Toyobo, for fully automated gene analysis system GENECUBE®
[ Chemicals | 2011-04-20]
Launch of ROMIPLATE® [250 mcg] for subcutaneous injection- Platelet producer stimulating thrombopoietin receptors for treatment of chronic Idiopathic Thrombocytopenic Purpura
[ Chemicals | 2011-04-13]
Regarding the effects of the Tohoku Pacific Coast Earthquake (2nd release)
[ Chemicals | 2011-03-23]
Regarding the effects of the Tohoku Pacific Coast Earthquake
[ Chemicals | 2011-03-14]
Notice of revisions to the financial summary press release Kyowa Hakko Kirin Fiscal 2010 Sales up 1.7%, Operating income up 46.8%
[ Chemicals | 2011-02-09]
(Revised Edition) Kyowa Hakko Kirin Fiscal 2010 Sales up 1.7%, Operating income up 46.8%
[ Chemicals | 2011-01-28]
Kyowa Hakko Kirin Fiscal 2010 Sales up 1.7%, Operating income up 46.8%
[ Chemicals | 2011-01-28]
Kyowa Hakko Kirin Announces Results from US Phase 1/2 Clinical Trial ofKW-0761 (Anti-CCR4 Humanized Monoclonal Antibody) in Patients with Cutaneous T-cell lymphoma
[ Chemicals | 2010-12-08]
Kyowa Hakko Kirin Announces Results from Japan Phase 2 Clinical Trial of KW-0761 (Anti-CCR4 Humanized Monoclonal Antibody) in Patients with Recurrent or Relapsed Adult T-Cell Leukemia-Lymphoma (ATL)
[ Chemicals | 2010-12-07]
Basic Agreement Reached on Sale of Consolidated Subsidiary
[ Chemicals | 2010-10-27]
Kyowa Hakko Kirin to enter licensing agreement with Lundbeck for A2a antagonist KW-6356
[ Chemicals | 2010-10-05]
Kyowa Hakko Kirin to enter out-licensing agreement with Biovail for anti-Parkinson's disease drug KW-6002 (Istradefylline) in North America
[ Chemicals | 2010-06-03]
Kyowa Hakko Bio announced the reorganization of Yamaguchi Production Center
[ Chemicals | 2010-05-25]
Appendix to the Fiscal 2010 First Quarter Consolidated Financial Statements
[ Chemicals | 2010-04-30]
Consolidated Financial Summary: First Quarter of the Fiscal Year to December 2010
[ Chemicals | 2010-04-28]
Kyowa Hakko Kirin Announces Q1 Growth in Sales and Profits
[ Chemicals | 2010-04-28]
Kyowa Hakko Kirin Forecasts 16.4% increase in 2010 Operating Income;2009 Results in line with Revised Forecasts
[ Chemicals | 2010-01-29]
« Previous12Next »



You may also like to check companies from Kyowa Hakko Kirin Co., Ltd.'s related industry or location as follows: Chemicals, Tokyo

Press Conferense Videos
Sharp and Semiconductor Energy Laboratory Jointly Develop New Oxide Semiconductor Technology That Will Revolutionize Displays Sharp and Semiconductor Energy Laboratory Jointly Develop New Oxide Semiconductor Technology That Will Revolutionize Displays
Sharp Corporation 2012/06/01
More Videos
Latest Press Release Search

Save favorite searches Hot keywords

Fukushima | power supply | cloud | solar
*NOTE: Recommended keywords shown above.
Your Most Recently Viewed Companies
Visit any of the company pages in JPubb, and your most recently viewed companies will automatically show up here.

Erase all This feature:ON How to use
Latest Releases: Kyowa Hakko Kirin Co., Ltd.
Conversion of Kyowa Hakko Kirin Korea Co., Ltd. into wholly owned subsidiary
2012/09/26
Kyowa Hakko Kirin returns to Otsuka Pharmaceutical the rights to develop and market Busulfex®, for use as a part of conditioning regimen prior to hematopoietic progenitor cell transplantation, in Japan and in Asian Countries & Regions
2012/09/14
Pasetocin® and Sawacillin®: Joint Application Seeking Approval for Additional Indication for Helicobacter pylori Eradication by Triple Therapy with Proton Pump Inhibitors and either Clarithromycin or Metronidazole
2012/08/31
Kyowa Hakko Kirin Initiates Pivotal Phase 2 Trial of Mogamulizumab (KW-0761) in Patients with Adult T-cell Leukemia-Lymphoma in the United States and Europe
2012/08/23
Launch of Apokyn® Subcutaneous Injection 30 mg for Treatment of Parkinson's Disease
2012/07/26
Feed
Releases by Prefecture
Hokkaido | Aomori | Iwate | Miyagi | Akita | Yamagata | Fukushima

Ibaraki | Tochigi | Gunma | Saitama | Chiba | Tokyo | Kanagawa

Niigata | Toyama | Ishikawa | Fukui | Yamanashi | Nagano

Gifu | Shizuoka | Aichi | Mie

Shiga | Kyoto | Osaka | Hyogo | Nara | Wakayama

Tottori | Shimane | Okayama | Hiroshima | Yamaguchi

Tokushima | Kagawa | Ehime | Kochi

Fukuoka | Saga | Nagasaki | Kumamoto | Oita | Miyazaki | Kagoshima | Okinawa
Releases by Stock Exchange
TSE (Tokyo) All | TSE1 | TSE2 | Mothers

OSE (Osaka) All | OSE1 | OSE2 | JASDAQ Standard | JASDAQ Growth

NSE (Nagoya) All | NSE1 | NSE2 | Centrex | NSE-only

SSE (Sapporo) All | Ambitious | SSE-only

FSE (Fukuoka) All | Q-Board | FSE-only
Press Release Search
Company
Industry
Prefecture
Stock Exchange
Date
(yyyy/mm/dd)		 //～
//
Listed or Non-listed
*NOTE: Please input only items to be specified.
*NOTE: The "date" here means the one on which a press release is uploaded on this website. So it isn't necessarily the same as its official announcement date.
Company Search
Company
Industry
Prefecture
Stock Exchange
Listed or Non-listed
*NOTE: Please input only items to be specified.